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Diabetes is strongly associated with cognitive decline, but the
molecular reasons are unknown. We found that fasting and
peripheral insulin promote phosphorylation and dephosphoryla-
tion, respectively, of specific residues on brain proteins including
cytoskeletal regulators suchas slit-roboGTPase-activatingprotein
3 (srGAP3) and microtubule affinity-regulating protein kinases
(MARKs), in which deficiency or dysregulation is linked to neuro-
logical disorders. Fasting activates protein kinase A (PKA) but not
PKB/Akt signaling in the brain, and PKA can phosphorylate the
purified srGAP3. The phosphorylation of srGAP3 and MARKs
were increased when PKA signaling was activated in primary neu-
rons. Knockdown of PKA decreased the phosphorylation of
srGAP3.Furthermore,WAVE1,aproteinkinaseA-anchoringpro-
tein, formedacomplexwith srGAP3andPKAin thebrainof fasted
mice to facilitate the phosphorylation of srGAP3 by PKA.
Althoughbraincells have insulin receptors, our findings are incon-
sistent with the down-regulation of phosphorylation of target pro-
teins beingmediated by insulin signaling within the brain. Rather,
our findings infer that systemic insulin, through a yet unknown
mechanism, inhibitsPKAorproteinkinase(s)withsimilar specific-
ity and/or activates anunknownphosphatase in thebrain. Ser858 of
srGAP3 was identified as a key regulatory residue in which phos-
phorylation by PKA enhanced the GAP activity of srGAP3 toward
its substrate, Rac1, in cells, thereby inhibiting the action of this
GTPase incytoskeletal regulation.Our findings revealnovelmech-
anisms linking peripheral insulin sensitivity with cytoskeletal
remodeling in neurons, whichmay help to explain the association
of diabetes with neurological disorders such as Alzheimer disease.
Insulin resistance is a hallmark of type II diabetes that comes
with major complications, such as nephropathy, retinopathy,
and heart disease. Moreover, recent studies have highlighted
the strong linkage of insulin resistance with an increased risk of
depression, cognitive decline, and Alzheimer disease (1, 2).
Together diabetes and dementia are reaching epidemic propor-
tions and have major social and financial consequences. How-
ever, the molecular basis of the association between diabetes
and brain decline is unknown. There is a common perception
that the complications of diabetes such as nephropathies, heart
disease, and cognitive decline are secondary consequences of
vascular problems caused by loss of glucose control (3). How-
ever, it seems logical that such disorders could also be more
direct consequences of dysregulated insulin action within the
damaged tissues (4, 5).
Although the brain as a whole is classically viewed as an insu-
lin insensitive organ, the insulin receptor (IR)5 is expressed in
brain regions including the olfactory bulb, hypothalamus, and
hippocampus (6). The signaling components downstream of IR
such as insulin receptor substrate-1 (IRS-1), PI 3-kinase, and
protein kinase B (PKB, also known as Akt) are widely expressed
in the brain (7). Insulin signaling in the brain is important in the
control of food intake (8), hepatic gluconeogenesis (9), energy
homeostasis, and reproductive endocrinology (10). Besides
these effects on metabolism and reproduction, insulin in the
brain also regulates circuit function and plasticity by control-
ling synapse density (11). In humans, intravenously adminis-
tered insulin under euglycemic hyperinsulinemic conditions
improves cognitive functions (12), and intranasally adminis-
tered insulin similarly results in an improvement in learning
and memory formation without affecting blood glucose levels
(13). Moreover, the brain in Alzheimer disease (AD) displays a
resistance to insulin that is associated with dysfunctional IRS-1
(14). The upstream IRS-1 serine kinases including glycogen
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synthase kinase 3 (GSK-3), IB kinase (IKK), JNK, and mecha-
nistic target of rapamycin (mTOR) are activated in the basal
state, resulting in higher basal IRS-1 serine phosphorylation.
The elevated basal IRS-1 serine phosphorylation consequently
causes insulin resistance in the brain in AD through down-
regulation of its tyrosine phosphorylation by the insulin recep-
tor (14). However, genetic ablation of the IR in mouse brain
causes insulin resistance in the central nervous system but does
not impair learning and memory formation (15). Therefore, it
remains unclear how insulin regulates cognitive performance.
In many organs, fasting triggers physiological changes oppo-
site to those elicited by insulin. As in other organs, fasting can
activate cAMP-dependent protein kinase A (PKA) in the brain
(16); the latter is important for many aspects of brain functions
through regulating various cellular activities such as gene tran-
scription (17) and receptor trafficking (18). Given the impor-
tance of PKA in learning and memory (17), it was therefore
intriguing to find out whether fasting/PKA signaling is con-
nected with insulin response in the brain.
During experiments to define molecular changes caused by
insulin inmultiple organs in vivo, we found that fasting induced
phosphorylation of a number of proteins in the brain, whereas
peripheral administration of insulin after a fast triggered
dephosphorylation of these proteins. We isolated these pro-
teins through an IP-MS (immunoprecipitation coupled with
mass spectrometry) approach. Among the identified proteins
were cytoskeleton regulators, namely slit-roboGTPase-activat-
ing protein 3 (srGAP3); Arf-GAP with GTPase, ANK, and PH
domain-containing protein 2 (AGAP2); and microtubule affin-
ity-regulating protein kinases (MARKs). These data revealed a
novel regulatory pathway by which fasting and peripheral insu-
lin regulates brain functions and which may help explain some
of the links between diabetes and neurological disorders.
Experimental Procedures
Materials—Recombinant human insulin was from Novo
Nordisk (Bagsvaerd, Denmark), forskolin and H-89 from Sell-
eckchem (Shanghai, China), and microcystin-LR from Enzo
Life Sciences (Farmingdale, NY). Precast NuPAGE bis-Tris
gels were fromThermo Fisher Scientific and proteinG-Sephar-
ose and glutathione-Sepharose 4B from GE Healthcare. All
other chemicals were from Sigma-Aldrich or Sangon Biotech
(Shanghai, China).
Antibodies—Antibodies against the HA tag and MARK4
were raised in sheep by the Division of Signal Transduction
Therapy (DSTT), University of Dundee (UK) as reported pre-
viously (19). The antibody against total srGAP3 was raised in
sheep by the DSTT, University of Dundee, using the recombi-
nant GST-srGAP3 proteins as immunogen. The site-specific
antibody against phospho-Ser858 on srGAP3 was raised in
sheep by the DSTT, University of Dundee, using the synthetic
phosphopeptide (GRVRLRpSDGAAIP, residues 852–864 of
human srGAP3, where bold italic pS represents phosphorylated
Ser858) as immunogen and column-purified against the same
phosphopeptide. FLAG antibody (catalogue No. F1804) and
GAPDH antibody (G8795) were from Sigma-Aldrich. Flotillin1
(FLOT-1) antibody (sc-25506), Bcl2 antibody (sc-7382), Bax
antibody (sc-7480), and PKA-C antibody (sc-903) were from
Santa Cruz Biotechnology. PKA2 antibody (ab75993) was
from Abcam. Antibodies that recognize phosphorylated Ser473
on PKB (catalogue No. 9271) and phosphorylated Ser133 on
cAMP response element-binding protein (CREB; catalogueNo.
9191), anti-PKB (catalogue No. 9272), anti-CREB (catalogue
No. 9197), the phospho-Akt substrate (PAS) antibody (cata-
logue No. 9611), the pS/T-PKA substrate antibody (catalogue
No. 9621), and immobilized PAS antibody (catalogueNo. 9646)
were from Cell Signaling Technology. The WAVE1 antibody
(catalogue No. 07-037) and SVP38 antibody (catalogue No.
MAB368) were from Millipore. The site-specific antibody rec-
ognizing phospho-Ser157 on VASP (catalogue No. 676604) was
from Calbiochem.
Molecular Biology—The cDNA encoding human srGAP3
(NM_014850) was cloned into the vector pcDNA5-FRT/
TO-HA for expression inmammalian cells. Residue numbering
of srGAP3 was according to the srGAP3 protein encoded by
this human cDNA. Point mutation of srGAP3 was carried out
using standard procedures. The sequence contexts of mutated
sites on srGAP3 are: GRVRLRsDGAAIP (Ser858 in lowercase
bold), AMRRSsSSSTEMM (Ser1029 in lowercase bold), and
AMRRSSsSSTEMM (Ser1030 in lowercase bold). The cDNA
encoding humanRac1 (NM_006908.4) was cloned into the vec-
tor pcDNA5-FRT/TO-FLAG for expression in mammalian
cells. The cDNA encoding the Pak1-PBD spanning Lys67 to
Ala150 of human Pak1 was cloned into the pGEX6P vector for
protein expression inEscherichia coli. All DNAconstructswere
sequenced either by the service managed by Nick Helps, Uni-
versity of Dundee, or by Life Technologies, Inc.
Mouse Husbandry and Procedures—Mouse husbandry and
procedures were approved by the Ethics Committees at the
University of Dundee and Nanjing University. C57Bl6 mice
were housed with a light/dark cycle of 12 h and free access to
food and water unless stated otherwise.
For insulin injection, mice deprived of food overnight (16 h)
were anesthetized with sodium pentobarbital (90 mg/kg of
body weight) and injected intraperitoneally with a bolus of
insulin (150 milliunits of insulin/g of body weight). For glucose
injection, mice deprived of food overnight (16 h) were injected
intraperitoneally with a bolus of glucose (2 g of glucose/kg of
body weight). Twenty minutes after injection with insulin or
glucose, the mice were killed for tissue collection via cervical
dislocation. For refeeding, mice were allowed free access to
food for 90min after fooddeprivation overnight (16 h) andwere
killed via cervical dislocation for tissue collection after
refeeding.
Tissue Homogenization and Measurement of Protein
Concentration—Mouse tissues were homogenized in lysis
buffer using a Polytron homogenizer (Kinematica, Switzer-
land) and further lysed on ice for 30 min as described previ-
ously (20). After lysis, tissue debris was removed from tissue
lysates through centrifugation, and the protein concentrations
of tissue lysates were determined using Bradford reagent
(Thermo Fisher Scientific).
Isolation of Primary Cortical Neurons and Cerebellar Gran-
ule Cells—Primary cortical neurons were isolated as described
previously (21). Briefly, neonatal pups (P0–P1) were killed by
decapitation, and the cerebral cortexwas removed, finely diced,
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and digested with trypsin. Dissociated cells were washed six
times in serum-free Neurobasal A medium before passing
through a 70-m cell strainer. Cortical neurons were then
plated on poly-D-lysine-coated dishes.
Primary cerebellar granule cells were isolated as described
previously (22). Briefly, neonatal pups (P4–P7) were killed by
decapitation, and the cerebellar external granule layer was dis-
sected out, finely diced, and digested with trypsin. Tissues were
triturated into a single cell suspension with fire-polished
pipettes and then allowed to gravity-precipitate. The single cell
suspensionwas passed through a 70-mcell strainer and plated
on poly-D-lysine-coated dishes.
Cell Culture, Transfection, Stimulation, and Lysis—Primary
cortical neurons were cultured in Neurobasal A medium con-
taining 1% fetal bovine serum (FBS), 0.4 mM glutamine, and 2%
B27 supplement. Primary cerebellar granule cells were cultured
in Neurobasal A medium containing 1% FBS, 2 mM glutamine
and 2%B27 supplement. HEK293 cells were cultured inDMEM
containing 10% FBS. HEK293 cells were transfected via a poly-
ethylenimine-mediated method as described previously (20).
The siRNAs for knockdown of the PKA catalytic subunits were
as described previously (23). For treatments with forskolin or
insulin, cells were deprived of serum for 12 h (basal) and then
stimulated as indicated with forskolin at 10M or insulin at 100
nM for 30 min. When H-89 was used, it was added to the cell
cultures at 10Mprior to stimulation with forskolin. Cells were
then lysed in ice-cold lysis buffer as described previously (24).
Immunoprecipitation—Immunoprecipitation was carried
out as described previously (24). Briefly, the indicated antibod-
ies were coupled to protein G-Sepharose and used for incuba-
tion with cell or brain lysates overnight at 4 °C. Following incu-
bation, unbound proteins were removed after centrifugation,
and resins were washed to remove nonspecific binding pro-
teins. Immunoprecipitates were then eluted from resins in SDS
sample buffer for subsequent analysis.
Electrophoresis and Immunoblotting—Cell or tissue lysates
or immunoprecipitates were separated electrophoretically on
commercial or laboratory-made gels. After electrophoresis,
proteins were immunoblotted onto nitrocellulose membranes
that were further incubated with the indicated primary anti-
bodies at 4 °C for 16 h. After being incubated with horseradish
peroxidase-conjugated secondary antibodies, the chemilumi-
nescent signals were detected using ECL (GE Healthcare).
Mass Spectrometry—After SDS-PAGE, colloidal Coomassie-
stained bands were excised, digested with trypsin, and analyzed
by LC-MS on an LTQ-Orbitrap (Thermo Finnigan) mass spec-
trometer coupled to a Dionex 3000 nano liquid chromatogra-
phy system as described previously (25). For peptide and pro-
tein identification, raw files were converted to peak lists in
Mascot generic format (MGF) files using raw2msm v1.7 soft-
ware (MatthiasMann), andMGF files were then searched using
a Mascot 2.2 in-house server against the Swiss-Prot database.
Only peptides with Mascot ion score over 25 were considered,
and only proteins with at least two unique peptides were con-
sidered. For phosphopeptide analysis, only phosphopeptides
with ion scores over 18 were considered. The individual
MS/MS spectra for the phosphopeptide ions were quantified
using Xcalibur 2.2 software.
In Vitro Phosphorylation—The recombinant GST-srGAP3
proteins were expressed in E. coli, purified using glutathione-
Sepharose 4B (GE Healthcare), and phosphorylated by a cata-
lytic subunit of PKA (V5161, Promega) in vitro at 30 °C for 30
min as described previously (20).
GAP Activity Measurement—The GAP activity of recombi-
nant GST-srGAP3 was measured with Rac1 as substrate using
the GAP assay kit (BK105, Cytoskeleton Inc.).
Measurement of Active Rac1 in Cell Lysates—For the Rac1
activation assay, cells were lysed in lysis buffer (50 mM HEPES/
KOH, pH 7.4, 100 mM NaCl, 4 mM MgCl2, 1 mM DTT, 1%
Nonidet P-40, 10% glycerol, 10 mM NaF, 1 mM Na3VO4, 1
mg/ml leupeptin, 1 mg/ml pepstatin, and 1 mg/ml aprotinin).
Purified recombinant GST-Pak1-PBDwas immobilized on glu-
tathione-Sepharose beads and incubated with cell lysates at
4 °C for 1 h. After nonspecifically bound proteinswere removed
by three washes with lysis buffer, the Pak1-PBD-bound active
Rac1was eluted from resins in SDS sample buffer andmeasured
via Western blot.
Statistical Analysis—Unless stated otherwise, the data were
analyzed via Student’s t test, and differences were considered
statistically significant at p 0.05.
Results
Intraperitoneal Injection of Insulin after a Fast Decreases
Phosphorylation of Proteins in the Brain—We collected organs
frommice that were injected intraperitoneally or not with insu-
lin and interrogated the response to insulin by analyzing phos-
pho-Ser473 of PKB and the phosphorylation of its potential
downstream targets detected with the PAS antibody. As
expected, the phosphorylation of PKB on Ser473 increased in
the fat and liver in response to insulin (Fig. 1A). The phosphor-
ylation of PKB on Ser473 was unchanged in the lysates of the
brains from the mice that were intraperitoneally injected with
insulin (Fig. 1A). By analyzing crude lysates, it became obvious
that insulin stimulates the phosphorylation ofmany proteins in
the fat and liver as detected with the PAS antibody (Fig. 1A).
However, in striking contrast to these organs, the PAS-binding
signals ofmany proteins were diminished in the crude lysates of
the brains from the mice subjected to intraperitoneal injection
of insulin (Fig. 1A).
These phosphoproteins were purified from mouse brain by
immunoprecipitation with the PAS antibody, digested with
trypsin, and identified using mass spectrometry (Fig. 1B and
supplemental Table 1). Among the proteins identified, AS160/
TBC1D4, GARNL1/RalGAP1, and RalGAP2 are known
PAS-binding proteins and PKB substrates (20, 24, 26). Taking
the Mascot score for each protein as a very approximate indi-
cator of protein abundance, the scores for these proteins
showednodecrease in the insulin-treated samples (supplemen-
tal Table 1). Furthermore, the PAS-binding signals and the
phosphorylation of the major PAS recognition site (Thr642)
were unaltered for the immunoprecipitated AS160 from the
brains of the insulin-treated mice (Fig. 1, C and D). In con-
trast, a number of other proteins had Mascot scores that
were markedly lower in the PAS-captured samples from the
brains of insulin-treated mice than the scores from fasted
animals (supplemental Table 1). Such proteins include reg-
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ulators of cytoskeletal reorganization, namely MARKs,
which are on the AMP-activated protein kinase branch of the
human kinome and regulate microtubule dynamics; srGAP3,
which is widely expressed in the brain and regulates the
directionality of cell polarity, axon extension, and migration
(27); and AGAP2, which is critical for the control of synaptic
insertion of the AMPA receptor (28). The diminished levels
of srGAP3 and AGAP2 in the PAS immunoprecipitates from
the brains of the insulin-treated mice were further con-
firmed via an immunoblotting assay using the srGAP3- and
AGAP2-specific antibodies, respectively (Fig. 1E). In a recip-
rocal experiment, the PAS-binding signals were markedly
decreased on the srGAP3 immunoprecipitated from the
brains of the insulin-treated mice (Fig. 1F). Because srGAP3
and MARKs have been implicated in certain neurological
diseases (29, 30), we subsequently focused on the regulation
of these proteins in this study.
Peripheral Insulin Sensitivity Links with Phosphorylation of
Target Proteins in the Brain—Insulin injection is nonphysi-
ological, andwhatwe had observed in the brain could have been
a secondary effect due to a fall in blood glucose or release of
stress hormones, especially as these animals were fasted over-
night. However, we suspect that insulin itself was the primary
trigger because the PAS-binding signals in the crude brain
FIGURE 1. Intraperitoneal injection of insulin triggers protein dephosphorylation in mouse brain. A, PAS antibody-reactive phosphorylation and phos-
phorylation of Ser473 of PKBwere detected in the lysates of brain, liver, and adipose tissue frommice subjected to overnight fasting (16 h) or to intraperitoneal
insulin injection (20 min) after an overnight fast. B, PAS antibody-reactive phosphoproteins were immunoprecipitated (IP) using immobilized PAS antibody
beads from brain lysates of mice subjected to overnight fasting (16 h) or to intraperitoneal insulin injection (20 min) after an overnight fast. The immunopre-
cipitated proteins, identified via mass spectrometry, included srGAP3, AGAP2, MARK3, and MARK4. C and D, the AS160 proteins were immunoprecipitated
using the AS160 antibody from brain lysates (2 mg) and muscle lysates (0.2 mg) of mice subjected to overnight fasting (16 h) or to intraperitoneal insulin
injection (20 min) after an overnight fast. PAS antibody-reactive phosphorylation (C) and Thr642 phosphorylation (D) of AS160 were detected in the immuno-
precipitates using the PAS antibody and the phospho-Thr642-specific antibody, respectively. IB, immunoblot. E, PAS antibody-reactive phosphorylated pro-
teins were immunoprecipitated using the immobilized PAS antibody beads frombrain lysates ofmice subjected to ad libitum feeding or overnight fasting (16
h) or to intraperitoneal insulin injection (20min) after an overnight fast. The levels of srGAP3 andAGAP2 in the immunoprecipitates using the immobilized PAS
antibody beads were detected using the specific antibodies recognizing srGAP3 and AGAP2, respectively. F, The srGAP3 proteins were immunoprecipitated
using the srGAP3 antibody from brain lysates of mice subjected to ad libitum feeding or overnight fasting (16 h) or to intraperitoneal insulin injection (20min)
after an overnight fast. The PAS antibody-reactive phosphorylation of srGAP3 was detected in the immunoprecipitates using the PAS antibody.
Insulin Sensitivity and Brain Protein Phosphorylation
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lysates and on immunoprecipitated srGAP3, MARK3, and
MARK4 from the brain lysates were also decreased when ani-
mals were injected with glucose or more physiologically
allowed to refeed after a fast (Fig. 2, A and B). A common
denominator for these conditions is increased blood insulin.
We next investigated whether insulin resistance in the
peripheral tissues affected the phosphorylation/dephosphory-
lation of srGAP3 in the brains of mice subjected to intraperito-
neal insulin injection after a fast. To this end, wild-type mice
were fed a high fat diet for 5 weeks to induce insulin resistance.
As expected, mice on the high fat diet displayed glucose intol-
erance (Fig. 2C), which indicated that they developed insulin
resistance. Again, intraperitoneal injection of insulin decreased
the PAS-binding signals on the srGAP3 immunoprecipitated
FIGURE 2. Peripheral insulin sensitivity modulates phosphorylation of target proteins in mouse brain. A and B, overnight fasted mice were injected
intraperitoneallywith insulin (20min) or glucose (20min) or allowed to refeedad libitum for 90min (threemice for each condition) beforebeing culled for brain
sampling. The PAS antibody-reactive phosphorylation was detected in brain lysates (A). The indicated proteins (srGAP3, MARK3, and MARK4) were immuno-
precipitated from lysates, and their phosphorylation was detected using the PAS antibody (B). C–E, mice were fed on either a chow diet or high fat diet (HFD)
for 5 weeks. The high fat diet induced insulin resistance in mice as evidenced by the glucose tolerance test (n 5) (C). Overnight fasted mice were injected
intraperitoneallywith saline or insulin (20min) before termination for brain sampling. The PAS antibody-reactive phosphorylationwas detectedon the srGAP3
proteins immunoprecipitated from brain lysates (D). The PAS antibody-reactive phosphorylation on the srGAP3 was then quantified (n  3) (E). Statistical
analysis was carried out using two-way analysis of variance. IP, immunoprecipitate; IB, immunoblot. F and G, TUNEL staining of brain sections of mice fed on
chow diet or high fat diet for 16 weeks. F, representative TUNEL staining of brain sections. G, quantitation of TUNEL positive cells. The data were summarized
from five brain sections for each condition. H, expression of SVP38, Bcl2, and Bax in homogenates of brains frommice fed on a chow diet or a high fat diet for
16 weeks. The data are given as the mean S.E.; *, p 0.05.
Insulin Sensitivity and Brain Protein Phosphorylation
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from the brain lysates of control mice on a chow diet (Fig. 2, D
and E). In contrast, intraperitoneal insulin injection caused a
less prominent decrease in PAS binding to srGAP3 immuno-
precipitated frommice on the high fat diet (Fig. 2,D and E). As
reported previously (31), we found that the high fat diet induced
apoptosis inmouse brain as evidenced by TUNEL staining (Fig.
2, F and G) and expression of apoptosis markers Bcl-2 and Bax
(Fig. 2H). The expression of a synaptic vesicle marker, SVP38,
was also decreased in the brain from high fat diet-fed mice
(Fig. 2H).
Fasting Increases the Phosphorylation of the Target Proteins
in the Brain—We next investigated how fasting regulated the
phosphorylation of the target proteins. To this end, mice were
fasted for various periods before sampling. We found that the
PAS-binding signals in the crude brain lysates and on immuno-
precipitated srGAP3 and MARK4 from the brain lysates were
all increased when the mice were fasted longer than 6 h (Fig. 3,
A andB). The Ser473 phosphorylation of PKBwas unchanged in
the brains of fasted mice, suggesting that PKB was not respon-
sible for the fasting-induced PAS-binding signals in the brain
(Fig. 3C). It has been shown that fasting can activate PKA in the
brain, which can increase phosphorylation of its substrate,
CREB (16, 32). As reported previously, we found that the Ser133
phosphorylation of CREB was increased in the brains of fasted
mice, and in contrast, intraperitoneal injection of insulin after a
fast decreased the Ser133 phosphorylation of CREB in the
lysates ofmouse brains (Fig. 3C).When a generic phospho-Ser/
Thr PKA substrate antibody was used to detect protein phos-
phorylation in mouse brains, a similar protein phosphorylation
pattern as detected with the PAS antibody was found in the
brains from fasted mice, and the phosphorylation signals
were strongly decreased in the brains from insulin-injected
mice (Fig. 3D). Together, these data suggest that PKAmight be
involved in the phosphorylation of the identified proteins such
as srGAP3 and MARKs in the brains of fasted mice.
Forskolin Stimulates the Phosphorylation of srGAP3,
MARK3, and MARK4 in Primary Neurons—Forskolin, an ade-
nyl cyclase activator that indirectly activates PKA through ele-
vating cellular cAMP, was used to treat primary cortical neu-
rons and cerebellar granule cells isolated from neonatal mice.
The PAS-binding signalsweremarkedly increased in the lysates
of cortical neurons upon stimulation with forskolin (Fig. 4A)
and presented a pattern similar to that observed in the brain
lysates of fasted mice. Similarly, forskolin also increased the
PAS-binding signals in the lysates of cerebellar granule cells,
which was prevented by pretreatment with the nonspecific
PKA inhibitor H-89 (Fig. 4B). The PAS-binding signals were
increased on the immunoprecipitated srGAP3 and MARK4
from the lysates of cortical neurons treated with forskolin (Fig.
4, C andD). Forskolin also markedly elevated the MARK3 pro-
tein levels in cortical neurons, which parallels the PAS-binding
signals on the immunoprecipitated MARK3 proteins (Fig. 4E).
Identification of Ser858 as a Regulatory Phosphorylation Site
on srGAP3—Wenext carried out a detailed analysis of the phos-
phorylation of srGAP3 inmouse brain. To this end, the srGAP3
proteins were immunoprecipitated from the brains of the mice
fasted overnight or injected with insulin after a fast (Fig. 5A),
and phosphopeptides were identified on the precipitated pro-
FIGURE3.Fasting inducesproteinphosphorylation inmousebrain.A andB,micewere subjected toad libitum feedingor deprivedof food for the indicated
time before termination for brain sampling. The PAS antibody-reactive phosphorylationwas detected in brain lysateswith FLOT-1 as a loading control (A). The
indicated proteins (srGAP3 and MARK4) were immunoprecipitated from lysates, and their phosphorylation was detected using the PAS antibody (B). C, mice
were subjected to ad libitum feeding or overnight fasting (16 h) or to intraperitoneal insulin injection (20 min) after an overnight fast before termination for
brain sampling. Total and phosphorylation of CREB and PKB were detected in brain lysates. D, protein phosphorylation was detected using a pS/T-PKA
substrate antibody in brain lysates of mice subjected to overnight fasting (16 h) or intraperitoneal insulin injection (20 min) after an overnight fast. IB,
immunoblot.
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teins via mass spectrometry. Fourteen phosphopeptides were
identified on the immunoprecipitated srGAP3 from mouse
brain lysates (Table 1). The phosphorylated residue could only
be precisely assigned for LRSDGAAIPR (Ser858 shown under-
lined), which displayed an over 2-fold decrease in ion intensity
when themice were injected intraperitoneally with insulin (Fig.
5B). The phospho-Ser858 and its surrounding sequence confer
the recognition motif RXRXXp(S/T) of the PAS antibody.
When Ser858 was substituted by a non-phosphorylatable ala-
nine, the PAS-binding signals on the srGAP3 were diminished
(Fig. 5C), suggesting that phospho-Ser858 is a primary binding
site on the srGAP3 for the PAS antibody. To further study the
phosphorylation of Ser858 on the srGAP3, we raised a site-spe-
cific phosphoantibody for phospho-Ser858. The specificity of
the phospho-Ser858 antibody was confirmed by (phospho)pep-
tide dot blots (data not shown) and immunoblotwith the S858A
mutant protein (Fig. 5C). The PAS-binding signals and phos-
pho-Ser858 signals were both increased on the wild-type
srGAP3 isolated from transfected cells stimulated with forsko-
lin, but the response to forskolin was diminished on the
srGAP3S858A mutant protein (Fig. 5D). Using the phospho-
Ser858-specific antibody,we further confirmed that Ser858 phos-
phorylation was decreased in the brain lysates of the mice that
were injected intraperitoneally with insulin (Fig. 5E). In the pri-
mary cortical neurons and cerebellar granule cells, forskolin
increased the phosphorylation of Ser858 on srGAP3, whereas
this forskolin-induced Ser858 phosphorylation was prevented
when cells were pretreated with the nonspecific PKA inhibitor
H-89 (Fig. 5, F andG). In contrast, insulin could neither activate
PKB, as evidenced by the Ser473 phosphorylation on PKB, nor
inhibit the forskolin-stimulated Ser858 phosphorylation on
srGAP3 in the lysates of treated cortical neurons (Fig. 5H), sug-
gesting that down-regulation of phosphorylation of srGAP3 in
the brain by systemic insulin administration (Fig. 5E) is not a
direct effect of insulin in neurons and requires a secondary
mediator that may derive from peripheral tissues.
PKA Forms a Complex with srGAP3 and WAVE1 and Phos-
phorylates srGAP3—It has been reported that the protein
kinase A-anchoring protein (AKAP) WAVE1 is a srGAP3-in-
teracting protein (33). Consistent with this report, we found
that HA-srGAP3 could be co-immunoprecipitated with GFP-
WAVE1 when these two proteins were co-expressed in cells
(Fig. 6,A and B). Substantial amount of endogenous PKA could
be detected in the immunoprecipitates (Fig. 6, A and B). When
endogenous srGAP3 was immunoprecipitated from brain
homogenates, endogenousWAVE1 and PKA could be detected
in the immunoprecipitates (Fig. 6C). Importantly, the amounts
of co-precipitated WAVE1 and PKA were substantially in-
creased in the immunoprecipitates of srGAP3 from homoge-
nates of fasted mice (Fig. 6C), which correlates with the
increased Ser858 phosphorylation of srGAP3 (Fig. 5E). These
data suggest that formation of the srGAP3-WAVE1-PKA com-
plex may facilitate the phosphorylation of srGAP3 by PKA. To
obtain more direct evidence that PKA phosphorylates srGAP3,
we knocked down PKA via siRNA in cells and found that Ser858
phosphorylation of srGAP3 was significantly decreased in par-
FIGURE 4. Forskolin induces the PAS antibody-reactive protein phosphorylation in primary neurons. A, primary cortical neurons were isolated from
neonatal mice and subjected to stimulation with forskolin. The PAS antibody-reactive phosphorylation was detected in cell lysates with FLOT-1 as a loading
control.B, primary cerebellar granule cellswere isolated fromneonatalmice and subjected to stimulationwith forskolin in thepresenceor absenceofH-89. The
PAS antibody-reactive phosphorylationwas detected in cell lysateswithGAPDHas a loading control.C–E, the indicated proteins (srGAP3,MARK3, andMARK4)
were immunoprecipitated from lysates of primary cortical neurons that were stimulated with or without forskolin, and their phosphorylation was detected
using the PAS antibody. IB, immunoblot.
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allel with a lower level of phosphorylation of CREB upon PKA
knockdown (Fig. 6, D–G). Together, these data show that PKA
is an upstream kinase that can phosphorylate Ser858 of srGAP3.
Phosphorylation of srGAP3 by PKA Increased Its GAP Activ-
ity toward Rac1—To further study how PKA-mediated phos-
phorylation regulates srGAP3, we carried out an in vitro phos-
phorylation of bacterially expressed and purified GST-srGAP3
fusionproteins using aPKAcatalytic subunit. The in vitrophos-
phorylated srGAP3 proteins could be detected using the PAS
antibody as well as the phospho-Ser858 antibody (Fig. 7A).
Consistent with a previous report (29), the full-length
srGAP3 recombinant protein displayed GAP activity toward
Rac1 (Fig. 7B). Interestingly, the in vitro phosphorylation of the
srGAP3 by PKA significantly increased its GAP activity toward
Rac1 (Fig. 7B). When the srGAP3 and Rac1 were co-expressed
inHEK293 cells, the srGAP3S858Amutant protein increased the
FIGURE 5. Phosphorylation of the srGAP3 induced by fasting in mouse brain and forkolin in primary neurons. A, the srGAP3 proteins were
immunoprecipitated (IP) from brain lysates and subjected to phosphomapping analysis via mass spectrometry. A.U., arbitrary unit. B, the srGAP3
proteins were immunoprecipitated from the brains of mice that were either fasted overnight (16 h) or intraperitoneally injected with insulin for 20 min
after an overnight fast. Phosphorylated Ser858 was detected and quantified by measuring the area detected by the relevant extracted ion chromato-
grams on the immunoprecipitated srGAP3 proteins. The quantified intensities under fasting conditions were set to one, and the intensities under insulin
injection conditions were normalized against the respective values under fasting conditions. The values shown are themean of two experiments. C, The
HA-tagged wild-type and mutant srGAP3 proteins were expressed in HEK293 cells. Phosphorylation of the HA-tagged srGAP3 proteins was detected
using the PAS antibody and pS858-srGAP3 phospho-specific antibody. Total HA-tagged srGAP3 was detected using the anti-HA antibody with GAPDH
as a loading control. The surrounding sequence for Ser1029 and Ser1030 is as follows: RRSssSSTEMM (Ser1029 and Ser1030 shown in lowercase bold letters).
D, HEK293 cells expressing the HA-tagged wild-type and mutant srGAP3 proteins were stimulated with or without forskolin. Phosphorylation of the
HA-tagged srGAP3 proteins was detected using the PAS antibody and pS858-srGAP3 phospho-specific antibody. Phosphorylated VASP was detected
using the pS157-VASP phospho-specific antibody with GAPDH as a loading control. E, the srGAP3 proteins were immunoprecipitated using the srGAP3
antibody frombrain lysates ofmice subjected to overnight fasting (16 h) or to intraperitoneal insulin injection (20min) after an overnight fast. The Ser858
phosphorylation of srGAP3 was detected in the immunoprecipitates using the pS858-srGAP3 phospho-specific antibody. F and G, primary cortical
neurons (F) and cerebellar granule cells (G) were isolated from neonatal mice and subjected to stimulation with forskolin (FSK) in the presence or
absence of H-89. The Ser858 phosphorylation of srGAP3 was detected in cell lysates using the pS858-srGAP3 phospho-specific antibody. Total and
phosphorylated CREB were detected in cell lysates with GAPDH as a loading control. The arrowhead in F indicates the signals for Ser858 phosphorylation
of srGAP3. H, primary cerebellar granule cells were isolated from neonatal mice and subjected to stimulation with forskolin, insulin, or both. Total and
phosphorylated PKB, srGAP3, and CREB were detected in cell lysates. IP, immunoprecipitate; IB, immunoblot.
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levels of the GTP-bound active form of Rac1 as compared with
thewild-type srGAP3, srGAP3S1029A, and srGAP3S1030Amutant
proteins (Fig. 7C), further suggesting that Ser858 phosphorylation
increases theGAPactivity of srGAP3.Consistentwith its effect on
Rac1 activation, expression of the srGAP3S858Amutant protein in
DU145 cells enhanced cell migration as compared with the wild-
type srGAP3 protein (Fig. 7D).
Discussion
In this study, we found that fasting induced phosphorylation
of a set of proteins in mouse brain, whereas peripheral admin-
istration of insulin down-regulated their phosphorylation in
the brain. The data presented here identify a novel regulatory
mechanism linking fasting and insulin to signal transduction in
the brain, which may help to elucidate the molecular basis of
the association between diabetes and brain decline in neurode-
generative diseases.
Over the last few years, brain insulin signaling has been a
focus of research aimed at unraveling the molecular mecha-
nisms that underlie the association of insulin sensitivity with
brain cognitive functions. Cumulative evidence indicates that
insulin resistance is associated with cognitive decline. For
instance, insulin response was markedly decreased in post-
mortem hippocampal formation of AD cases as compared with
normal cases (14). The levels of a number of insulin signaling
molecules including IR, IRS-1, and PKB were significantly
reduced in the post-mortem frontal cortex of individuals with
both AD and type II diabetes (34). However, brain insulin resis-
tance caused by deletion of IR in mouse brain did not affect
learning andmemory formation (15). It has been proposed that
compensatory mechanismsmay operate in the absence of IR to
prevent brain decline (35). An alternative hypothesis is that
peripheral insulin resistance contributes to cognitive impair-
ment in neurodegeneration, enhanced by factors such as vascu-
lar lesions and the generation of neurotoxic lipids (36). Our
results show that peripheral injection of insulin down-regulates
the phosphorylation of a set of proteins in the brain, whereas
insulin treatment of primary neurons does not alter the phos-
phorylation of these proteins, which is in line with this latter
hypothesis. Our findings raise key questions about the nature of
the mediator (if there is such) that transduces the peripheral
insulin signaling into the brain, which phosphatase is activated
or which kinase is inhibited in the brain upon peripheral injec-
FIGURE 6. PKA forms a protein complex with srGAP3 and WAVE1 and phosphorylates srGAP3 in cells. A and B, HA-srGAP3 and GFP-WAVE1 were
co-expressed in HEK293 cells. A, GFP-WAVE1 was immunoprecipitated from cell lysates, and HA-srGAP3, the endogenous PKA catalytic subunit, and the
regulatory subunit were detected in the immunoprecipitates. B, in a reciprocal experiment, HA-srGAP3 was immunoprecipitated from cell lysates, and
GFP-WAVE1 and the endogenous PKA catalytic subunit were detected in the immunoprecipitates. C, endogenous srGAP3 was immunoprecipitated from
homogenates of brains of mice subjected to either ad libitum (ad lib) or overnight fasting (16 h). Endogenous WAVE1 and the PKA catalytic subunit were
detected in the immunoprecipitates. D–G, Ser858 phosphorylation of srGAP3 upon knockdown of PKA. PKA catalytic subunit was knocked down via siRNA in
HEK293 cells expressing HA-srGAP3. Phosphorylation and expression of HA-srGAP3, CREB, and PKA were determined via Western blot using tubulin as a
loading control.D, representative immunoblots (IB). E–G, quantitativedata,n5. Thedata aregivenas themean S.E.; *,p0.05. IP, immunoprecipitate;A.U.,
arbitrary unit; siNC, negative control siRNA.
TABLE 1
Phosphopeptides identified on the srGAP3 in mouse brain
The srGAP3 proteins were immunoprecipitated from lysates of mouse brains, and
phosphopeptides were detected on the immunoprecipitated srGAP3 proteins via
mass spectrometry. The known modified residue is underlined. NA, not applicable
(indicating that phosphorylated residues are present but cannot be assigned
precisely).
Peptide name P site
R.LRSDGAAIPR.R  p(S/T) Ser858
R.SSSSSTEMMTTFKPALSAR.L  p(S/T) NA
R.RSSSSSTEMMTTFKPALSAR.L  p(S/T) NA
R.SSSSSSSGVGSPAVTPTEK.M  2 p(S/T) NA
R.MATFGSAGSINYPDKK.A  p(S/T) NA
R.AAACPSSPHKIPLSR.G  p(S/T) NA
R.SSSSSSSGVGSPAVTPTEK.M  p(S/T) NA
R.STESIKSAASETYMSK.I  2 p(S/T) NA
R.STESIKSAASETYMSK.I  p(S/T) NA
R.SGGDTHSPPRGLGPSIDTPPR.A  2 p(S/T) NA
K.NDLQSPTEHISDYGFGGVMGR.V  p(S/T) NA
K.ASSKNDLQSPTEHISDYGFGGVMGR.V  p(S/T) NA
R.SGGDTHSPPRGLGPSIDTPPR.A  p(S/T) NA
R.HSSLGDHKSLEAEALAEDIEK.T  2 p(S/T) NA
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tion of insulin to mediate the down-regulation of phosphoryla-
tion of the target proteins, and whether this decrease in protein
phosphorylation regulates cognitive functions and, if so, how.
Although we have established that acute fasting induces the
phosphorylation of a set of target brain proteins, the identity of
the relevant kinase(s) in vivo remains unclear; however, several
lines of evidence suggest PKA might be the one. In primary
neurons, the PKA-activating agent forskolin increases phos-
phorylation of a similar set of target proteins in which the over-
all pattern detected by the PAS antibody is similar to the one in
the brain induced by acute fasting, indicating that PKA might
be the responsible kinase in the brain. The in vitro phosphory-
lation of srGAP3 by PKA and the decreased phosphorylation of
srGAP3 upon knockdown of PKA in cells are also consistent
with this kinase being a candidate for phosphorylation of the
target proteins in the brain. In cells, AKAPs interact with both
PKA and its substrates, bringing them into proximity for PKA
to phosphorylate its substrates (37). It has been shown that the
srGAP3 interacts with WAVE1, a known AKAP (33, 38). Our
findings that fasting induces the formation of an srGAP3-
WAVE1-PKA complex in mouse brain further indicates that
PKA could be the kinase that phosphorylates Ser858 of srGAP3
in fasted animals. The activation of PKA involves the cAMP-
stimulated dissociation of the regulatory subunit of PKA from
its catalytic subunit (39), which makes it difficult to measure
PKA activation directly in the brain. However, the phosphory-
lation of CREB, a known PKA substrate, indicates that PKAwas
activated in the brain by acute fasting as reported previously
(32). The phosphorylation of CREB is proposed to mediate the
antidepressant-like effects of acute fasting (32). It will be inter-
esting to investigate whether the phosphoproteins discovered
in this study also contribute to the antidepressant-like effects of
acute fasting.
Cytoskeleton dynamics play an essential role in maintaining
brain functions, and dysregulations of cytoskeletal proteins are
linked to neurodegenerative diseases (40). The MARKs can
phosphorylate the microtubule-associated proteins MAP4,
MAP2c, andTau on theirmicrotubule-binding domains, which
consequently detach these microtubule-associated proteins
from microtubules and increase the dynamic instability of
microtubules (41, 42). In primary rat hippocampal neurons,
overexpression of MARK4 causes Tau hyperphosphorylation
FIGURE 7. Ser858 phosphorylation of srGAP3 increases its GAP activity toward Rac1. A, GST-srGAP3 proteins were phosphorylated by PKA in vitro. The
phosphorylation of GST-srGAP3 was detected using the PAS antibody or pS858-srGAP3 phospho-specific antibody. B, GST-srGAP3 proteins were phosphory-
lated by PKA in vitro, and their GAP activities toward Rac1was determined. n 3. The data are given as themean S.E.; *, p 0.05. C, the HA-taggedwild-type
and mutant srGAP3 proteins were co-expressed with the FLAG-tagged Rac1 in HEK293 cells. The GTP-Rac1 was determined via immunoblotting after being
isolated from cell lysates using recombinant Pak1-RBD. D, the wild-type and mutant srGAP3 proteins were expressed in DU145 human prostate cancer cells,
and cell migration was measured using Corning Transwell inserts. At the end of the Transwell assay, the migrated cells were fixed, stained with crystal violet,
and counted (n 9). The data are given as the mean S.E.; *, p 0.05.
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and results in synaptic toxicity (43). Elevated MARK4 expres-
sion andMARK4-Tau interactions were found in post-mortem
human AD brains, further highlighting the importance of this
kinase in AD (44). The MARKs are activated via phosphoryla-
tion of the threonine residue in the activation loop by upstream
kinases including LKB1 (19) andMARKK/TAOK1 (45). In con-
trast, glycogen synthase kinase 3 (GSK-3) inhibits MARK2 by
phosphorylating Ser212 of this kinase (46). Therefore, it will be
critical to carry out a detailed study in the future to address how
the phosphorylation of the MARKs detected by the PAS anti-
body regulates their activities and whether their deregulation
contributes to AD or other tauopathies. A further cytoskeleton
regulator identified in this study is srGAP3, which influences
cytoskeleton dynamics through the down-regulation of Rac1
signaling (27, 47, 48). Loss of the srGAP3 in humans has been
linked tomental retardation (29), and deletion of the srGAP3 in
mice impairs learning and memory by affecting dendritic spine
formation (49, 50). Therefore, our discoveries suggest that fast-
ing and systemic insulin signaling regulates brain cytoskeleton
dynamics and brain functions through controlling the phos-
phorylation of the MARKs and srGAP3.
Taken together, our findings reveal a novel regulatory mech-
anism that links fasting and systemic insulin sensitivity to brain
functions. In the longer term, dissecting the underlying mech-
anismmore precisely may identify therapeutic targets and pro-
vide “biomarkers” to track aspects of diabetes other than glu-
cose-related effects, so that damaging changes can be detected
early.
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